Results
|
|
61.
|
|
|
|
62.
|
|
|
|
63.
|
|
|
|
64.
|
|
|
|
65.
|
|
|
|
66.
|
|
|
|
67.
|
|
|
|
68.
|
|
|
|
69.
|
|
|
|
70.
|
|
|
|
71.
|
[Kidney transplantation from living, related donors]. [electronic resource] by
- Gofrit, O
- Eid, A
- Friedlander, M
- Rubinger, D
- Brautbar, C
- Shiloni, E
- Reissman, P
- Rivkind, A
- Durst, A
- Berlatzki, Y
Producer: 19950612
In:
Harefuah vol. 128
Availability: No items available.
|
|
|
72.
|
[CA15-3 tumor marker in early detection of breast cancer]. [electronic resource] by
- Roisman, I
- Shiloni, E
- Lifshiz, I
- Shoshani, D
- Saphir, D
- Honigman, I
- Livni, N
- Sherman, Y
- Papo, O
- Durst, A L
Producer: 19920520
In:
Harefuah vol. 122
Availability: No items available.
|
|
|
73.
|
|
|
|
74.
|
|
|
|
75.
|
Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma. [electronic resource] by
- Lotem, M
- Shiloni, E
- Pappo, I
- Drize, O
- Hamburger, T
- Weitzen, R
- Isacson, R
- Kaduri, L
- Merims, S
- Frankenburg, S
- Peretz, T
Producer: 20040326
In:
British journal of cancer vol. 90
Availability: No items available.
|
|
|
76.
|
|
|
|
77.
|
|
|
|
78.
|
|
|
|
79.
|
Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint Committee on Cancer. [electronic resource] by
- Lotem, M
- Peretz, T
- Drize, O
- Gimmon, Z
- Ad El, D
- Weitzen, R
- Goldberg, H
- Ben David, I
- Prus, D
- Hamburger, T
- Shiloni, E
Producer: 20020802
In:
British journal of cancer vol. 86
Availability: No items available.
|
|
|
80.
|
Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. Tumor inhibition by IL-2 but not tumor necrosis factor. [electronic resource] by
- Karp, S E
- Farber, A
- Salo, J C
- Hwu, P
- Jaffe, G
- Asher, A L
- Shiloni, E
- Restifo, N P
- Mulé, J J
- Rosenberg, S A
Producer: 19930222
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 150
Availability: No items available.
|